Seattle Womens: Health, Research, Gynecology

Seattle, Washington 98115

1 studies enrolling now · 33 studies all time

What they study most

Acute Migraine, Candida Vulvovaginitis, Candidiasis, Vulvovaginal, Contraception, Dyspareunia, Endometriosis, Female Sexual Arousal Disorder, Hot Flashes, Menopause, Migraine, Migraine, With or Without Aura, Moniliasis, Vulvovaginal

Studies at this site

• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine — Stopped early
• A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain — Completed
• Evaluation of the Efficacy and Safety of LevoCept — Completed
• Evaluation of the Efficacy, Safety, and Tolerability of LevoCept — Starting soon
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
• Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study — Completed
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2 — Completed
• A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause — Completed
• Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine — Completed
• Intended Use Study of the BD SurePath Plus™ Pap — Stopped early
• Randomized Trial in Adult Participants With Acute Migraines — Completed
• Safety and Efficacy Study in Adult Subjects With Acute Migraines — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Trial in Adult Subjects With Acute Migraines — Completed
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• Dysport in Vulvodynia Phase II Study — Stopped early
• Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis — Completed
• Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder — Status unconfirmed
• An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections — Completed
• A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) — Completed
• Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles — Completed
• A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms — Completed
• Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women — Completed
• Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization — Completed
• LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study — Completed
• A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy — Completed
• Safety, Efficacy and Pharmacokinetics of ALD403 — Completed
• Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) — Stopped early
• Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder — Completed
• Efficacy and Safety Study of an Oral Contraceptive in Healthy Females — Completed